{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:56:09Z","timestamp":1788494169532,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T00:00:00Z","timestamp":1664150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170278"],"award-info":[{"award-number":["82170278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1908205"],"award-info":[{"award-number":["U1908205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.biopha.2022.113765","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T14:48:02Z","timestamp":1665413282000},"page":"113765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Dapagliflozin attenuates residual cardiac remodeling after surgical ventricular reconstruction in mice with an enlarged heart after myocardial infarction"],"prefix":"10.1016","volume":"156","author":[{"given":"Siyuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuegang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangjun","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cankun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2022.113765_bib1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/eurjhf\/hfq020","article-title":"End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy","volume":"12","author":"Di Donato","year":"2010","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.biopha.2022.113765_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.14503\/THIJ-16-6068","article-title":"Left ventricular reconstruction for postinfarction left ventricular aneurysm: review of surgical techniques","volume":"44","author":"Ruzza","year":"2017","journal-title":"Tex. Heart Inst. J."},{"issue":"7","key":"10.1016\/j.biopha.2022.113765_bib3","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2004.07.017","article-title":"Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation","volume":"44","author":"Athanasuleas","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113765_bib4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0022-5223(19)36221-X","article-title":"Left ventricular aneurysm with predominating congestive heart failure. A comparative study of medical and surgical treatment","volume":"94","author":"Louagie","year":"1987","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"10","key":"10.1016\/j.biopha.2022.113765_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206120","article-title":"Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia","volume":"13","author":"Niriayo","year":"2018","journal-title":"PLoS. One"},{"issue":"19","key":"10.1016\/j.biopha.2022.113765_bib6","first-page":"1463","article-title":"Avoiding non-responders to cardiac resynchronization therapy: a practical guide","volume":"38","author":"Daubert","year":"2017","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.biopha.2022.113765_bib7","first-page":"199","article-title":"Real world use of hypertonic saline in refractory acute decompensated heart failure: a U.S. Center's Experience, JACC","volume":"8","author":"Griffin","year":"2020","journal-title":"Heart Fail"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2022.113765_bib8","first-page":"S30","article-title":"Role of isolated ultrafiltration in the management of chronic refractory and acute decompensated heart failure","volume":"20","author":"Mittal","year":"2016","journal-title":"Hemodial. Int."},{"key":"10.1016\/j.biopha.2022.113765_bib9","article-title":"Partial vena cava occlusion (VCO) to counteract refractory heart failure: a new era in interventional heart failure strategy","volume":"66","author":"Sattar","year":"2021","journal-title":"Ann. Med. Surg. (Lond. )"},{"issue":"17","key":"10.1016\/j.biopha.2022.113765_bib10","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary bypass surgery with or without surgical ventricular reconstruction","volume":"360","author":"Jones","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113765_bib11","article-title":"Outcomes after surgical ventricular restoration for ischemic cardiomyopathy","author":"Stefanelli","year":"2020","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"18","key":"10.1016\/j.biopha.2022.113765_bib12","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.4244\/EIJ-D-19-00225","article-title":"A transcatheter procedure for direct modification of the aneurysmatic left ventricle","volume":"16","author":"Wang","year":"2021","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.biopha.2022.113765_bib13","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/ejhf.1669","article-title":"Less invasive ventricular reconstruction for ischaemic heart failure","volume":"21","author":"Klein","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.biopha.2022.113765_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-020-01208-z","article-title":"Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF","volume":"20","author":"Bode","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2022.113765_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2021.2632","article-title":"Extrapolating long-term event-free and overall survival with dapagliflozin in patients with heart failure and reduced ejection fraction: an exploratory analysis of a phase 3 randomized clinical trial","author":"Docherty","year":"2021","journal-title":"Jama. Cardiol."},{"issue":"21","key":"10.1016\/j.biopha.2022.113765_bib16","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113765_bib17","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.biopha.2022.113765_bib18","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.athoracsur.2015.05.119","article-title":"Residual stress impairs pump function after surgical ventricular remodeling: a finite element analysis","volume":"100","author":"Pantoja","year":"2015","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2022.113765_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbrc.2015.06.117","article-title":"Ablation of C\/EBP homologous protein increases the acute phase mortality and doesn't attenuate cardiac remodeling in mice with myocardial infarction","volume":"464","author":"Luo","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"23","key":"10.1016\/j.biopha.2022.113765_bib20","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/CIRCULATIONAHA.120.047000","article-title":"Antihypertrophic memory after regression of exercise-induced physiological myocardial hypertrophy is mediated by the long noncoding RNA Mhrt779","volume":"143","author":"Lin","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.biopha.2022.113765_bib21","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1016\/j.ultrasmedbio.2017.07.020","article-title":"Echocardiographic strain analysis for the early detection of myocardial structural abnormality and initiation of drug therapy in a mouse model of dilated cardiomyopathy","volume":"43","author":"Zheng","year":"2017","journal-title":"Ultrasound Med. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113765_bib22","article-title":"Overexpression of Na, Biochim","volume":"1866","author":"Chen","year":"2020","journal-title":"Biophys. Acta Mol. Basis. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.113765_bib23","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.18632\/aging.202448","article-title":"Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome","volume":"13","author":"Hao","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"10.1016\/j.biopha.2022.113765_bib24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehr005","article-title":"Telemonitoring in chronic heart failure","volume":"32","author":"Hasan","year":"2011","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.biopha.2022.113765_bib25","first-page":"422","article-title":"Left ventricular reconstruction surgery in ischemic heart disease: a systematic review of the past two decades","volume":"60","author":"Doulamis","year":"2019","journal-title":"J. Cardiovasc. Surg. (Torino)."},{"issue":"3","key":"10.1016\/j.biopha.2022.113765_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.21037\/acs-2021-ami-17","article-title":"Surgical ventricular reconstruction for ischemic cardiomyopathy-a systematic review and meta-analysis of 7,685 patients","volume":"11","author":"Ferrell","year":"2022","journal-title":"Ann. Cardiothorac. Surg."},{"key":"10.1016\/j.biopha.2022.113765_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.789493","article-title":"A modified surgical ventricular reconstruction in post-infarction mice persistently alleviates heart failure and improves cardiac regeneration","volume":"8","author":"Ma","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"10.1016\/j.biopha.2022.113765_bib28","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.biopha.2022.113765_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007879","article-title":"Patient characteristics, clinical outcomes, and effect of dapagliflozin in relation to duration of heart failure: is it ever too late to start a new therapy","volume":"13","author":"Yeoh","year":"2020","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.biopha.2022.113765_bib30","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/dc19-2187","article-title":"Dapagliflozin versus placebo on left ventricular remodeling in patients with diabetes and heart failure: the REFORM trial","volume":"43","author":"Singh","year":"2020","journal-title":"Diabetes Care."},{"key":"10.1016\/j.biopha.2022.113765_bib31","article-title":"A bioinformatics investigation into the pharmacological mechanisms of sodium-glucose Co-transporter 2 inhibitors in diabetes mellitus and heart failure based on network pharmacology","author":"Mai","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"7","key":"10.1016\/j.biopha.2022.113765_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021814","article-title":"Migraine-associated mutation in the Na,K-ATPase Leads to disturbances in cardiac metabolism and reduced cardiac function","volume":"11","author":"Staehr","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.biopha.2022.113765_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13652","article-title":"The Na\/K-ATPase alpha1\/Src interaction regulates metabolic reserve and Western diet intolerance","volume":"232","author":"Kutz","year":"2021","journal-title":"Acta Physiol. (Oxf. )."},{"issue":"2","key":"10.1016\/j.biopha.2022.113765_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1254\/jphs.FMJ04008X2","article-title":"Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor gamma, CREB-binding protein, and adiponectin","volume":"97","author":"Tsuchida","year":"2005","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.113765_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng829","article-title":"Increased insulin sensitivity despite lipodystrophy in Crebbp heterozygous mice","volume":"30","author":"Yamauchi","year":"2002","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.biopha.2022.113765_bib36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41467-021-27533-9","article-title":"A propolis-derived small molecule ameliorates metabolic syndrome in obese mice by targeting the CREB\/CRTC2 transcriptional complex","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2022.113765_bib37","article-title":"Blockage of fibronectin 1 ameliorates myocardial ischemia\/reperfusion injury in association with activation of AMP-LKB1-AMPK signaling pathway","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.biopha.2022.113765_bib38","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1038\/s41598-022-13291-1","article-title":"Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis","volume":"12","author":"Pujar","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.113765_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12902-021-00718-5","article-title":"Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules","volume":"21","author":"Prashanth","year":"2021","journal-title":"Bmc. Endocr. Disord."},{"issue":"7","key":"10.1016\/j.biopha.2022.113765_bib40","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s00125-019-4859-4","article-title":"Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease","volume":"62","author":"Heerspink","year":"2019","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.biopha.2022.113765_bib41","first-page":"543","article-title":"Direct effects of empagliflozin on extracellular matrix remodelling in human cardiac myofibroblasts: novel translational clues to explain EMPA-REG OUTCOME results","volume":"36","author":"Kang","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2022.113765_bib42","first-page":"121","article-title":"The function study on the interaction between Grb2 and AMPK","author":"Pan","year":"2008","journal-title":"Mol. Cell. Biochem. 307(1-2) ("},{"issue":"5","key":"10.1016\/j.biopha.2022.113765_bib43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ncb3514","article-title":"SWELL1 is a regulator of adipocyte size, insulin signalling and glucose homeostasis","volume":"19","author":"Zhang","year":"2017","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.biopha.2022.113765_bib44","article-title":"Grb2 Induces cardiorenal syndrome type 3: roles of IL-6, cardiomyocyte bioenergetics, and Akt\/mTOR pathway","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"31","key":"10.1016\/j.biopha.2022.113765_bib45","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1074\/jbc.M117.784553","article-title":"Cardiac myocyte p38alpha kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart","volume":"292","author":"Rose","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2022.113765_bib46","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.2337\/db13-0095","article-title":"Myocardial loss of IRS1 and IRS2 causes heart failure and is controlled by p38alpha MAPK during insulin resistance","volume":"62","author":"Qi","year":"2013","journal-title":"Diabetes"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222011544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222011544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:15:10Z","timestamp":1778242510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222011544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":46,"alternative-id":["S0753332222011544"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113765","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin attenuates residual cardiac remodeling after surgical ventricular reconstruction in mice with an enlarged heart after myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113765"}}